Susquehanna Fundamental Investments’s Organogenesis Holdings ORGO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,328	Closed	-$122K	–	931
2025 Q1	$122K	Buy	+28,328	New	+$114K	﹤0.01%	1022
2024 Q2	$51.6K	Sell	18,435 -54,494	-75%	-$146K	﹤0.01%	915
2024 Q1	$207K	Buy	+72,929	New	+$248K	0.01%	616
2023 Q3	–	Sell	-12,853	Closed	-$42.7K	–	530
2023 Q2	$42.7K	Sell	12,853 -96,732	-88%	-$286K	﹤0.01%	627
2023 Q1	$233K	Sell	109,585 -39,034	-26%	-$96.4K	0.01%	835
2022 Q4	$400K	Sell	148,619 -67,684	-31%	-$197K	0.01%	925
2022 Q3	$701K	Buy	+216,303	New	+$977K	0.01%	916
2022 Q1	–	Sell	-15,628	Closed	-$144K	–	1649
2021 Q4	$144K	Buy	+15,628	New	+$166K	﹤0.01%	1297

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's ORGO Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 28,328 shares — an estimated $122K sold.

Susquehanna Fundamental Investments first reported a position in ORGO in Q4 2021 and held it in 8 quarters. The position peaked at $701K in Q3 2022. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 28,328 Organogenesis Holdings shares in Q2 2025, an estimated $122K.
Susquehanna Fundamental Investments first reported a position in Organogenesis Holdings in Q4 2021 and held it in 8 quarters.
Susquehanna Fundamental Investments's Organogenesis Holdings position peaked at $701K in Q3 2022.
115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.